MSM Supplements: A Commodity Molecule, So Cost Per Gram Is What Matters
MSM (methylsulfonylmethane, or dimethyl sulfone) is a commodity — the identical molecule in every bottle, so the only honest axis is cost per gram of MSM, and here it ranges more than 12x ($0.032–$0.40/g). Powder is far cheaper than capsules or tablets. The evidence is modest and mixed: two small knee-osteoarthritis pilots reported differences in physical function scores, but pain didn't reach significance in one of them (Debbi 2011, p=0.08). The one quality signal is OptiMSM (branded, distilled, traceable purity) — a sourcing signal, not proof it works better.
Educational overview — not medical advice. MSM has been studied for joint comfort and exercise recovery, with modest, mixed evidence — if you have significant joint pain, see a clinician. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Ranked by cost per gram of MSM, never commissions.
Start here
What MSM is (and why the brand hype misses the point)
MSM is methylsulfonylmethane, also written dimethyl sulfone — a small, sulfur-containing molecule that occurs naturally and is manufactured to a defined chemical spec. Because it's a single, well-characterized compound, MSM is a commodity: the molecule in a $14 powder is the same molecule in a $32 capsule. That's the key fact that reframes the whole category. There's no "cranberry PAC" style hidden active to hunt for and no bioavailable-form debate the way there is with magnesium — so the marketing (mega-milligram claims, "advanced" blends, proprietary names) is mostly noise layered on an identical ingredient. What actually differs between bottles is how much MSM you get per dollar and, secondarily, whether the maker documents its purity and sourcing (the OptiMSM signal).
Does it work? (the short version)
The evidence is mixed. Two small, short knee-osteoarthritis pilot trials gave limited results: Kim 2006 (6 g/day) reported changes in WOMAC pain and physical function scores, and Debbi 2011 (~3.4 g/day) reported significant differences in physical function and total WOMAC score — but in that trial pain did not reach statistical significance (p=0.08). Exercise-recovery work is thinner still: small pilots (Withee 2017; Kalman 2012) show trends in soreness with no reliable effect on muscle-damage or oxidative markers. The honest read: modest, mixed evidence, and nothing here shows MSM treats joint pain.
The one-line takeaway Since the molecule is identical everywhere and the evidence is modest, the smart move is to not overpay: buy the cheapest grams, and treat the OA/recovery evidence as modest and mixed.
The buying problem: form and blends, not "potency"
Two things drive real cost differences, and neither is on the front of the bottle in dollars. First, form: powder is far cheaper per gram than capsules or tablets, because you're not paying for pill-making and capsule shells — the same grams of MSM can cost several times more in capsule form. Second, blends: glucosamine-chondroitin-MSM combinations bury a small, often undisclosed MSM dose inside a pricey multi-ingredient product, so the effective cost per gram of MSM is far higher and sometimes incomputable. OptiMSM sits alongside these as a purity/sourcing signal — worth something if you value documented distillation and traceability, but not a reason to assume a better effect (see the full ranking).
On this page
Does MSM Work? What the Evidence Really Shows
Knee joint studies: function scores, pain uncertain
MSM's most-studied area is the knee joint, and even there it's two small, short pilot trials pointing more clearly at physical function scores than at pain. Kim 2006 reported changes in WOMAC pain and physical function scores — but published significance rather than exact effect sizes, so the magnitude isn't quantifiable from the trial. Debbi 2011 found significant changes in physical function and total WOMAC — while pain did not reach statistical significance (p=0.08) and stiffness was not significant either. Read together, the honest summary is a possible modest change in function scores, with the pain result genuinely uncertain.
What the trials show — and where they stop
Four small human trials carry most of the weight. Read them for what they actually measured, not the headline:
| Study | Design / dose | Finding | The honest limit |
|---|---|---|---|
| Kim 2006 PMID 16309928 | Knee pilot RCT | Changes in WOMAC pain and physical function scores vs placebo (significance reported) | Small, short pilot; exact effect sizes not published — treat as a signal, not a magnitude |
| Debbi 2011 PMID 21708034 | Knee RCT | Physical function & total WOMAC scores significant; pain NOT significant (p=0.08); stiffness NS | The pain benefit missed significance — the more reliable change was in function scores |
| Withee 2017 PMID 28736511 | Half-marathon RCT; 3 g/day OptiMSM | Post-exercise pain down clinically but not statistically; no effect on muscle-damage or oxidative markers | Doesn't measurably reduce exercise-induced muscle damage or oxidative stress |
| Kalman 2012 PMID 23013531 | Exercise pilot; n=8; 1.5 & 3 g/day | Soreness/fatigue trends (not significant); some antioxidant-marker shifts | Tiny pilot (8 people) — hypothesis-generating, not confirmatory |
Read together: the knee pilots reported a modest change in function scores, with the pain signal present in one trial (Kim) but not significant in the other (Debbi, p=0.08). The exercise-recovery work is weaker — a small, clinically-but-not-statistically meaningful dip in soreness and, importantly, no measurable effect on muscle damage or oxidative stress (Withee 2017). These are small studies (roughly 50 people or fewer), so treat MSM as having modest signals, not proven effects.
The claim to be careful with It's tempting to say MSM "significantly reduces joint pain" and "cuts exercise oxidative stress." Neither is well supported: the more rigorous OA trial found pain did not reach significance (Debbi 2011, p=0.08), and the half-marathon trial found no effect on oxidative-stress or muscle-damage markers (Withee 2017). The defensible statements are narrower: a possible modest change in function scores in two small knee pilots, and perhaps a small subjective dip in soreness.
What to keep in mind
- The evidence is modest — two small knee pilots and two small exercise studies.
- An add-on, not a replacement — MSM is inexpensive and well tolerated in studies, which is much of its appeal.
- Value-minded buyers — since the molecule is identical across brands and the evidence is modest, there's no reason to overpay: buy the cheapest grams that hit your label serving.
Set expectations honestly, and see a clinician if you have significant, worsening, or red-flag joint symptoms — MSM does not replace medical evaluation of a joint problem.
Verification check · MSM
What we could and could not verify about MSM
Not one of the 13 MSM products we track appears in the NSF, USP or Informed Sport registries. A “cGMP” line audits the factory, not the MSM bottle you would actually receive.
Method: our MSM roster matched against the full public registries of third-party-certified supplements in the US, NSF/ANSI 173, USP Verified and Informed Sport, 5,317 listings, retrieved 2026-08-25. Absence means nobody independent has checked that MSM product, not that it failed. Full method and limitations.
Frequently asked questions
What is MSM and does the brand matter?
MSM is methylsulfonylmethane (dimethyl sulfone), a commodity molecule that's chemically identical across brands. So cost per gram of MSM is the honest comparison. OptiMSM is a distilled, traceable-purity sourcing signal — not proof of a better effect.
What have joint studies of MSM found?
Modest and mixed. Two small knee-osteoarthritis pilots reported differences in physical function scores (Kim 2006; Debbi 2011), but pain wasn't significant in Debbi (p=0.08). Recovery pilots show trends only. Nothing here shows MSM treats joint pain.
What amounts have been studied?
Trials used ~1.5–6 g/day (OA pilots ~3–6 g; recovery pilots 1.5–3 g). A safety review reported it well tolerated up to ~4 g/day (Butawan 2017). Since the molecule is identical, compare cost per gram.
Is OptiMSM better than generic?
No head-to-head trial shows it works better — the molecule is the same. OptiMSM documents distillation and purity, so it's a sourcing signal. And it isn't always pricier: an OptiMSM powder is among the cheapest per gram in our data.
Related guides
- Best glucosamine chondroitin supplement — the joint ingredient MSM is most often blended with (and its own evidence picture)
- Does MSM work? — the honest, modest OA and recovery evidence, plus safety
- MSM cost per gram — why the commodity framing changes how you shop
Sources
- Kim LS, et al. "Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial." Osteoarthritis Cartilage. 2006. PMID: 16309928
- Debbi EM, et al. "Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study." BMC Complement Altern Med. 2011. PMID: 21708034 (function/total significant; pain NS, p=0.08).
- Butawan M, et al. "Methylsulfonylmethane: applications and safety of a novel dietary supplement." Nutrients. 2017. PMID: 28300758 (safety review; well tolerated).
- Full product dataset: /msm/cost-by-brand.json (CC BY 4.0).
- Withee ED, et al. "Effects of methylsulfonylmethane (MSM) on exercise-induced oxidative stress, muscle damage, and pain following a half-marathon: a double-blind, randomized, placebo-controlled trial." J Int Soc Sports Nutr. 2017. PMID: 28736511 (pain down clinically not statistically; no effect on damage/oxidative markers).
- Kalman DS, et al. "Influence of methylsulfonylmethane on markers of exercise recovery and performance in healthy men: a pilot study." J Int Soc Sports Nutr. 2012. PMID: 23013531 (n=8 pilot; trends).